Adaptive Biotechnologies
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ADPT and other ETFs, options, and stocks.About ADPT
Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. Its products and services include immunoSEQ, clonoSEQ, cellular therapy, and vaccines.
CEOChad Robins
CEOChad Robins
Employees619
Employees619
HeadquartersSeattle, Washington
HeadquartersSeattle, Washington
Founded2009
Founded2009
Employees619
Employees619
ADPT Key Statistics
Market cap2.48B
Market cap2.48B
Price-Earnings ratio-20.02
Price-Earnings ratio-20.02
Dividend yield—
Dividend yield—
Average volume1.64M
Average volume1.64M
High today$17.20
High today$17.20
Low today$16.28
Low today$16.28
Open price$17.00
Open price$17.00
Volume1.55M
Volume1.55M
52 Week high$17.62
52 Week high$17.62
52 Week low$4.27
52 Week low$4.27
ADPT News
Barchart 2d
Can This Red-Hot Biotech Stock Live Up to Wall Street’s Expectations?Adaptive Biotechnologies (ADPT) is a commercial-stage biotech with strong technical momentum. Shares are up 250% in the past year and just hit a new three-year...
TipRanks 5d
Adaptive Biotechnologies price target raised to $20 from $15 at Piper SandlerPiper Sandler raised the firm’s price target on Adaptive Biotechnologies (ADPT) to $20 from $15 and keeps an Overweight rating on the shares. The firm notes it...
Analyst ratings
88%
of 8 ratingsBuy
87.5%
Hold
12.5%
Sell
0%
People also own
Based on the portfolios of people who own ADPT. This list is generated using Robinhood data, and it’s not a recommendation.